Morpholino

MO1-gars1

ID

ZDB-MRPHLNO-180511-1

Name

MO1-gars1

Previous Names

Target

Sequence

5' - TGCGCTACACAGAGACAGCATGGAC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-gars1

Expressed Gene	Anatomy	Figures
syt2b	CaP motoneuron axon	Fig. 3 from Holloway et al., 2016

Phenotype

Phenotype resulting from MO1-gars1

Phenotype	Fish	Figures
axon development disrupted, abnormal	WT + MO1-gars1	Fig. 2 from Holloway et al., 2016
axonogenesis involved in innervation disrupted, abnormal	WT + MO1-gars1	Fig. 3 from Holloway et al., 2016
CaP motoneuron axon syt2b expression decreased amount, abnormal	WT + MO1-gars1	Fig. 3 from Holloway et al., 2016
CaP motoneuron axon decreased length, abnormal	WT + MO1-gars1	Fig. 2 from Holloway et al., 2016

Phenotype of all Fish created by or utilizing MO1-gars1

Phenotype	Fish	Conditions	Figures
CaP motoneuron axon syt2b expression decreased amount, abnormal	WT + MO1-gars1	standard conditions	Fig. 3 from Holloway et al., 2016
visual behavior process quality, abnormal	WT + MO1-gars1	chemical treatment by environment: vincristine sulfate	Fig. 4, Fig. S4 from Holloway et al., 2016
axon development disrupted, abnormal	WT + MO1-gars1	standard conditions	Fig. 2 from Holloway et al., 2016
axonogenesis involved in innervation disrupted, abnormal	WT + MO1-gars1	standard conditions	Fig. 3 from Holloway et al., 2016
swimming behavior process quality, abnormal	WT + MO1-gars1	chemical treatment by environment: vincristine sulfate	Fig. 4, Fig. S4 from Holloway et al., 2016
CaP motoneuron axon decreased length, abnormal	WT + MO1-gars1	standard conditions	Fig. 2 from Holloway et al., 2016
muscle neuromuscular junction increased amount, abnormal	WT + MO1-gars1	chemical treatment by environment: vincristine sulfate	Fig. 4 from Holloway et al., 2016
swimming behavior process quality, ameliorated	WT + MO1-gars1	chemical treatment by environment: paclitaxel, chemical treatment by environment: vincristine sulfate	Fig. S4 from Holloway et al., 2016
visual behavior process quality, ameliorated	WT + MO1-gars1	chemical treatment by environment: paclitaxel, chemical treatment by environment: vincristine sulfate	Fig. S4 from Holloway et al., 2016

Citations